Literature DB >> 7846480

Cigarette smoking and drinking of alcohol are not associated with rapid progression to acquired immunodeficiency syndrome among homosexual men in Norway.

A Eskild1, G Petersen.   

Abstract

In order to study the influence of cigarette smoking and drinking of alcohol on the progression to acquired immunodeficiency syndrome (AIDS), eighty HIV infected homosexual men were included in a prospective study from the date of diagnosed HIV seropositivity. Two men were lost to follow-up. The mean follow-up time was 62 months. By the end of the follow-up period 26 out of 78 subjects (33%) were diagnosed with AIDS. When controlling for age, year of HIV diagnosis, number of male lifetime partners and frequency of receptive anal intercourse, the adjusted relative risk of being diagnosed with AIDS for the group smoking 1-20 cigarettes daily was 0.4 (0.2-1.2, 95% confidence interval) and 1.1 (0.4-2.7, 95% confidence interval) for the group smoking more than 20 cigarettes daily, as opposed to the non-smoking group. The adjusted relative risk of progression to AIDS for daily alcohol drinkers as opposed to less frequent drinkers was 0.8 (0.3-2.2, 95% confidence interval). The adjusted relative risks of receptive anal intercourse often or usually and more than 500 lifetime male partners were 2.2 and 2.0, respectively. These estimates, however, were not significantly above 1.0. The lack of positive association between cigarette smoking, drinking of alcohol and progression to AIDS found in this study as well as in other studies, may have implication for the understanding of the pathogenesis of the HIV disease and for counselling HIV infected subjects.

Entities:  

Mesh:

Year:  1994        PMID: 7846480     DOI: 10.1177/140349489402200309

Source DB:  PubMed          Journal:  Scand J Soc Med        ISSN: 0300-8037


  9 in total

Review 1.  Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD.

Authors:  R N van Zyl Smit; M Pai; W W Yew; C C Leung; A Zumla; E D Bateman; K Dheda
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

Review 2.  The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.

Authors:  Richard N van Zyl-Smit; Laurence Brunet; Madhukar Pai; Wing-Wai Yew
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

Review 3.  Adding fuel to the fire: alcohol's effect on the HIV epidemic in Sub-Saharan Africa.

Authors:  Judith A Hahn; Sarah E Woolf-King; Winnie Muyindike
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

Review 4.  Is smoking tobacco an independent risk factor for HIV infection and progression to AIDS? A systemic review.

Authors:  A S Furber; R Maheswaran; J N Newell; C Carroll
Journal:  Sex Transm Infect       Date:  2006-08-21       Impact factor: 3.519

5.  Recent cigarette smoking and HIV disease progression: no evidence of an association.

Authors:  Conrad Kabali; Debbie M Cheng; Daniel R Brooks; Carly Bridden; C Robert Horsburgh; Jeffrey H Samet
Journal:  AIDS Care       Date:  2011-06-28

Review 6.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions.

Authors:  Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet
Journal:  Alcohol Clin Exp Res       Date:  2016-09-22       Impact factor: 3.455

Review 7.  Alcohol and HIV disease progression: weighing the evidence.

Authors:  Judith A Hahn; Jeffrey H Samet
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

Review 8.  Effect of cigarette smoking on HIV acquisition, progression, and mortality.

Authors:  Mariah M Marshall; Meredith C McCormack; Gregory D Kirk
Journal:  AIDS Educ Prev       Date:  2009-06

Review 9.  Chronic alcohol abuse and HIV disease progression: studies with the non-human primate model.

Authors:  Angela M Amedee; Whitney A Nichols; Spencer Robichaux; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.